Will a new subtype of Parkinson's Disease identified in the study lead to a new clinical trial by the end of 2024?

Will Caroline Uhler and Xinyi Zhang's team publish another significant AI-driven medical study by the end of 2024?

Will AI models from the study be adopted in clinical settings for breast cancer staging by the end of 2024?

Which subtype of Parkinson's Disease identified in the study will be the focus of the first new drug development by the end of 2024?

Which stage of breast cancer identified in the study will be the first to have a new treatment protocol developed by the end of 2024?

Which institution will be the first to adopt the AI model for breast cancer staging in clinical practice by the end of 2024?